Gene Therapy for Genetic Neurodegenerative Disorders by Cultured Microglia Cell for Gene Delivery

通过培养小胶质细胞进行基因传递治疗遗传性神经退行性疾病

基本信息

项目摘要

Gene delivery into the brain via blood vessels is quite difficult because of the blood-brain-barrier (BBB). It is speculated that microglia cells would go through BBB.We established a strain of cultured microglia cell from newborn mice brain for the vehicle of gene into the brain. The cells were labeled with a reporter gene of GFP and injected into the left ventricle of heart of Sly mice. Sly mouse, the deficiency of β-glucuronidase, is a mouse model for human disease of mucopolys accharidosis type VII, which is a systemic disorder including the brain caused by the accumulation of glycosaminoglycans. It is suggested that delivery of the deficient enzyme or the gene into each organ would improve the disease.In the literature, a number of experiments of gene therapy for the brain have been done, but none of them has not been successful. In our study, the cultured microglia cells could enter the brain tissue via blood vessel only when BBB was injured by the disease progression, but they do not go through normal BBB.
由于血脑屏障(BBB)的存在,通过血管将基因递送到脑中是相当困难的。我们建立了一株体外培养的新生小鼠脑小胶质细胞,作为基因进入脑的载体。将细胞用GFP报告基因标记并注射到Sly小鼠的左心室中。β-葡萄糖醛酸苷酶缺乏的Sly小鼠是人类粘多糖病VII型的小鼠模型,粘多糖病VII型是一种由糖胺聚糖蓄积引起的包括大脑在内的全身性疾病。在文献中,已经进行了许多脑基因治疗的实验,但没有一个是不成功的。本研究中,培养的小胶质细胞只有在疾病进展导致血脑屏障损伤时才能通过血管进入脑组织,而不通过正常血脑屏障。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nagano T, Nakamura A, Konno D, Kurata M, Yagi H, Sato M: "A2-Pancortins (Pancortin-3 and -4) are the dominant Pancortins during neocortical development."J.Neurochem.. 75. 1-8 (2000)
Nagano T、Nakamura A、Konno D、Kurata M、Yagi H、Sato M:“A2-Panchortin(Pancortin-3 和 -4)是新皮质发育过程中的主要 Pancortin。”J.Neurochem.. 75. 1-8 (
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Oya Y,Proia RL et al.: "Distribution of enzyme-bearing cells in GM2 gangliosidosis nice : regionally specific pattern of cellular infiltration following bone marrow transplantation."Acta Neuropathol.. 99. 161-168 (2000)
Oya Y、Proia RL 等人:“GM2 神经节苷脂沉积症中含酶细胞的分布很好:骨髓移植后细胞浸润的区域特异性模式。”Acta Neuropathol.. 99. 161-168 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Keng VW, Yagi H, Ikawa M, Nagano T, Myint Z, Yamada K, Tanaka T, Sato A, Muramatsu I, Okabe M, Sato M, Noguchi T: "Homeobox gene Hex is essential for onset of mouse embrionicliver development."Biochem.Biophys.Res.Commun.. 1276. 1155-1161 (2000)
Keng VW、Yagi H、Ikawa M、Nagano T、Myint Z、Yamada K、Tanaka T、Sato A、Muramatsu I、Okabe M、Sato M、Noguchi T:“同源框基因 Hex 对于小鼠胚胎肝发育的开始至关重要。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kimura M, Tanabe K, Krishna S, Tsuboi T, Saito-Ito A, Otani S, Ogura H: "Gametocyte-dominant expression of a novel P-type ATPase in Plasmodium yoelii."Mol.Biochem.Parasitol.. 104. 331-336 (1999)
Kimura M、Tanabe K、Krishna S、Tsuboi T、Saito-Ito A、Otani S、Ogura H:“约氏疟原虫中一种新型 P 型 ATP 酶的配子细胞显性表达。”Mol.Biochem.Parasitol.. 104. 331
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Saitoh S,Oiso N et al.: "Oculocutaneous albinizm type 2 with a P gene missence mutation in a patient with Angelman syndrome"J.Ned.genet.. 37・5. 392-394 (2000)
Saitoh S、Oiso N 等:“Angelman 综合征患者中伴有 P 基因错失突变的 2 型眼皮肤白化病”J.Ned.genet.. 37・5 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANAKA Akemi其他文献

TANAKA Akemi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANAKA Akemi', 18)}}的其他基金

Experimental study for the treatment of neuronal degeneration in lysosomal storage diseases by modification of autophagy
修饰自噬治疗溶酶体贮积症神经元变性的实验研究
  • 批准号:
    23591511
  • 财政年份:
    2011
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental study of immune responses in cell transplantation therapy for genetic neurodegenerative disorders
细胞移植治疗遗传性神经退行性疾病免疫反应的实验研究
  • 批准号:
    20591229
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Effect of Cell Fusion with the Host Brain Cells on the Neuronal Differentiation of Transplanted Mesenchymal Stem Cells in the Brain
细胞与宿主脑细胞融合对脑内移植间充质干细胞神经元分化的影响
  • 批准号:
    18591163
  • 财政年份:
    2006
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishing of cell strain from mouse ES cells for the therapeutic use and study in neurodegenerative disorders
从小鼠 ES 细胞中建立细胞株,用于神经退行性疾病的治疗和研究
  • 批准号:
    15591125
  • 财政年份:
    2003
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targetting of the brain by cultured microglia cell for neurofrgenerative disorders.
通过培养的小胶质细胞靶向大脑治疗神经再生障碍。
  • 批准号:
    11557060
  • 财政年份:
    1999
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The enzyme activity sites and the conjugation sites for dimers formation in hexosaminidase S (α α) and B (ββ)
氨基己糖苷酶 S (α α) 和 B (ββ) 中形成二聚体的酶活性位点和结合位点
  • 批准号:
    10670750
  • 财政年份:
    1998
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mutations in beta-hexosaminidase beta-subunit gene and the clinical phenotypes
β-己糖胺酶β亚基基因突变与临床表型
  • 批准号:
    08670905
  • 财政年份:
    1996
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies of Gene Abnormalities, Protein Abnormalities, and Their Phenotypes in Lysosomal Diseases.
溶酶体疾病中基因异常、蛋白质异常及其表型的研究。
  • 批准号:
    06670818
  • 财政年份:
    1994
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 7.23万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了